Seeking Alpha

The FDA has proposed new rules that would require the makers of emergency defibrillators to...

The FDA has proposed new rules that would require the makers of emergency defibrillators to submit data clinical-trial data for their devices or provide other evidence that they work. The move comes after 45,000 malfunctions and 88 product recalls from 2005-2012. Leading manufacturers include Philips (PHG), Physio-Control and Zoll Medical (ZOLL).
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs